Ajitha Dammalapati

517 total citations
12 papers, 475 citations indexed

About

Ajitha Dammalapati is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Ajitha Dammalapati has authored 12 papers receiving a total of 475 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in Ajitha Dammalapati's work include Neuroendocrine Tumor Research Advances (5 papers), Hedgehog Signaling Pathway Studies (3 papers) and Lung Cancer Research Studies (3 papers). Ajitha Dammalapati is often cited by papers focused on Neuroendocrine Tumor Research Advances (5 papers), Hedgehog Signaling Pathway Studies (3 papers) and Lung Cancer Research Studies (3 papers). Ajitha Dammalapati collaborates with scholars based in United States. Ajitha Dammalapati's co-authors include Herbert Chen, Renata Jaskula‐Sztul, Shaoqin Gong, April D. Harrison, Guojun Chen, Wenjin Xu, Weiping Tang, Jacob G. Eide, Corinne R. Esquibel and Qifeng Zheng and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and Cancer Research.

In The Last Decade

Ajitha Dammalapati

12 papers receiving 473 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ajitha Dammalapati United States 9 219 195 150 116 72 12 475
Xuelian Yin China 12 312 1.4× 194 1.0× 138 0.9× 175 1.5× 27 0.4× 26 521
Bajarangprasad L. Pandey India 10 279 1.3× 269 1.4× 395 2.6× 143 1.2× 45 0.6× 11 662
Wenya Zhou China 13 146 0.7× 228 1.2× 167 1.1× 67 0.6× 35 0.5× 19 469
Liuzhi Zhou China 10 236 1.1× 183 0.9× 119 0.8× 185 1.6× 38 0.5× 16 512
Elizabeth Higbee‐Dempsey United States 12 173 0.8× 165 0.8× 132 0.9× 104 0.9× 75 1.0× 13 523
Pablo Juanes‐Velasco Spain 9 120 0.5× 133 0.7× 87 0.6× 103 0.9× 50 0.7× 26 402
Alicia Landeira‐Viñuela Spain 9 117 0.5× 132 0.7× 84 0.6× 100 0.9× 50 0.7× 23 400
Zishan Zeng China 16 479 2.2× 162 0.8× 213 1.4× 204 1.8× 72 1.0× 23 684
Zilin Guan China 10 338 1.5× 130 0.7× 137 0.9× 144 1.2× 98 1.4× 13 526

Countries citing papers authored by Ajitha Dammalapati

Since Specialization
Citations

This map shows the geographic impact of Ajitha Dammalapati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ajitha Dammalapati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ajitha Dammalapati more than expected).

Fields of papers citing papers by Ajitha Dammalapati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ajitha Dammalapati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ajitha Dammalapati. The network helps show where Ajitha Dammalapati may publish in the future.

Co-authorship network of co-authors of Ajitha Dammalapati

This figure shows the co-authorship network connecting the top 25 collaborators of Ajitha Dammalapati. A scholar is included among the top collaborators of Ajitha Dammalapati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ajitha Dammalapati. Ajitha Dammalapati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Jang, Samuel, Xiao-Min Yu, Celina Montemayor, et al.. (2017). Dysadherin specific drug conjugates for the treatment of thyroid cancers with aggressive phenotypes. Oncotarget. 8(15). 24457–24468. 3 indexed citations
2.
Jang, Samuel, Matthew B. Robers, April D. Harrison, et al.. (2017). Histone deacetylase inhibitor thailandepsin-A activates Notch signaling and suppresses neuroendocrine cancer cell growthin vivo. Oncotarget. 8(41). 70828–70840. 9 indexed citations
3.
Chen, Guojun, Renata Jaskula‐Sztul, Corinne R. Esquibel, et al.. (2017). Neuroendocrine Tumor‐Targeted Upconversion Nanoparticle‐Based Micelles for Simultaneous NIR‐Controlled Combination Chemotherapy and Photodynamic Therapy, and Fluorescence Imaging. Advanced Functional Materials. 27(8). 158 indexed citations
4.
Jaskula‐Sztul, Renata, Wenjin Xu, Guojun Chen, et al.. (2016). Thailandepsin A-loaded and octreotide-functionalized unimolecular micelles for targeted neuroendocrine cancer therapy. Biomaterials. 91. 1–10. 55 indexed citations
5.
Chen, Guojun, Renata Jaskula‐Sztul, April D. Harrison, et al.. (2016). KE108-conjugated unimolecular micelles loaded with a novel HDAC inhibitor thailandepsin-A for targeted neuroendocrine cancer therapy. Biomaterials. 97. 22–33. 44 indexed citations
6.
Jaskula‐Sztul, Renata, Guojun Chen, Ajitha Dammalapati, et al.. (2016). AB3-loaded and tumor-targeted unimolecular micelles for medullary thyroid cancer treatment. Journal of Materials Chemistry B. 5(1). 151–159. 23 indexed citations
7.
Jaskula‐Sztul, Renata, Jacob G. Eide, Ajitha Dammalapati, et al.. (2014). Tumor-Suppressor Role of Notch3 in Medullary Thyroid Carcinoma Revealed by Genetic and Pharmacological Induction. Molecular Cancer Therapeutics. 14(2). 499–512. 38 indexed citations
8.
Wyche, Thomas P., Ajitha Dammalapati, Glen S. Kwon, et al.. (2014). Thiocoraline activates the Notch pathway in carcinoids and reduces tumor progression in vivo. Cancer Gene Therapy. 21(12). 518–525. 26 indexed citations
9.
Eide, Jacob G., Ajitha Dammalapati, Thomas P. Wyche, et al.. (2013). Thiocoraline alters neuroendocrine phenotype and activates the Notch pathway in MTC‐TT cell line. Cancer Medicine. 2(5). 734–743. 13 indexed citations
10.
Jaskula‐Sztul, Renata, et al.. (2013). Abstract 1014: Thailandepsin A, a new HDAC inhibitor, reduces cellular proliferation and activates the Notch pathway in human carcinoids cancer cells.. Cancer Research. 73(8_Supplement). 1014–1014. 1 indexed citations
11.
Xiao, Yuling, Renata Jaskula‐Sztul, Alireza Javadi, et al.. (2012). Co-delivery of doxorubicin and siRNA using octreotide-conjugated gold nanorods for targeted neuroendocrine cancer therapy. Nanoscale. 4(22). 7185–7185. 104 indexed citations
12.
Jaskula‐Sztul, Renata, et al.. (2012). Thiocoraline activates transcription of notch and inhibits the proliferation of carcinoid tumor cells. Planta Medica. 78(11). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuelian Yin Breakdown of academic impact, for papers by Bajarangprasad L. Pandey Breakdown of academic impact, for papers by Wenya Zhou Breakdown of academic impact, for papers by Liuzhi Zhou Breakdown of academic impact, for papers by Elizabeth Higbee‐Dempsey Breakdown of academic impact, for papers by Pablo Juanes‐Velasco Breakdown of academic impact, for papers by Alicia Landeira‐Viñuela Breakdown of academic impact, for papers by Zishan Zeng Breakdown of academic impact, for papers by Zilin Guan
Rankless by CCL
2026